DIEGO
ARANGO DEL CORRO
CON
Tel Aviv University
Tel Aviv, IsraelPublications in collaboration with researchers from Tel Aviv University (2)
2023
-
Polyoxazoline-Based Nanovaccine Synergizes with Tumor-Associated Macrophage Targeting and Anti-PD-1 Immunotherapy against Solid Tumors
Advanced Science, Vol. 10, Núm. 25
2019
-
Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer
Journal of Controlled Release, Vol. 307, pp. 108-138